Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant <i>Staphylococcus aureus</i> Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid

<table>Mean length of hospitalization.</table>

Journal of Pathogens

fig2

Figure 2

Figure 2: Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant <i>Staphylococcus aureus</i> Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid 

Figure 2 | Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant Staphylococcus aureus Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid 